Vaklavas C, Stringer-Reasor EM, Elkhanany AM, Ryan KJ, et al. A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast Cancer Res Treat 2023 Feb 3. doi: 10.1007/s10549-023-06864.
PMID: 36735117